The Times Of Central Asia | Eurasian Publication & News Online [Unofficial]Diagnosis and a Suitcase: Why Kazakhstanis with Cancer Still Seek Treatment Abroad
KillBait NewsNew targeted cancer drugs show promising results but chemotherapy remains essential for now
📰 Original title: Smart cancer drugs could replace chemotherap
🤖 IA: It's clickbait ⚠️
👥 Users: It's clickbait ⚠️
New targeted cancer drugs show promising results but chemotherapy remains essential for now
New research presented at the American Society of Clinical Oncology (ASCO) conference in Chicago highlights significant progress in cancer treatment through precision-targeted drugs and personalized therapies. One of the most discussed developments was an experimental drug, GRWD5769, designed to help the immune system recognize and attack cancer cells. When combined with immunotherapy, it achieved tumor reductions of at least 30 percent across multiple cancer types, with 26 out of 83 patients showing meaningful improvement. Another promising advancement involves Darasxnorasib, a daily pill for pancreatic cancer patients. In clinical trials involving 500 individuals, the drug nearly doubled average survival time compared to standard chemotherapy, increasing it from approximately 6.6 months to 13.2 months. Researchers described this as a major step forward for a disease known for its poor prognosis. The OPTIMA trial, led by University College London, demonstrated how genetic testing can identify breast cancer patients who may safely avoid chemotherapy. Among 4,000 participants, low-risk individuals were successfully treated with hormone therapy alone. Similarly, new treatment combinations for bladder cancer are helping patients avoid invasive surgery. Despite these encouraging results, experts warn that cancer rates are expected to rise significantly, from 165 cases per 100,000 people in 2025 to 200 by 2050. Annual diagnoses could increase from 20 million to over 35 million globally due to aging populations and demographic changes. Additional studies also highlighted lifestyle factors. Chronic insomnia was linked to a higher risk of several cancers among younger adults, while practices such as yoga were shown to improve mental health and reduce fatigue in patients. Overall, while targeted therapies are advancing rapidly, they are not yet a complete replacement for chemotherapy but represent an important shift toward more personalized cancer care.
KillBaitNew targeted cancer drugs show promising results but chemotherapy remains essential for now
📰 Original title: Smart cancer drugs could replace chemotherap
🤖 IA: It's clickbait ⚠️
👥 Users: It's clickbait ⚠️
New targeted cancer drugs show promising results but chemotherapy remains essential for now
New research presented at the American Society of Clinical Oncology (ASCO) conference in Chicago highlights significant progress in cancer treatment through precision-targeted drugs and personalized therapies. One of the most discussed developments was an experimental drug, GRWD5769, designed to help the immune system recognize and attack cancer cells. When combined with immunotherapy, it achieved tumor reductions of at least 30 percent across multiple cancer types, with 26 out of 83 patients showing meaningful improvement. Another promising advancement involves Darasxnorasib, a daily pill for pancreatic cancer patients. In clinical trials involving 500 individuals, the drug nearly doubled average survival time compared to standard chemotherapy, increasing it from approximately 6.6 months to 13.2 months. Researchers described this as a major step forward for a disease known for its poor prognosis. The OPTIMA trial, led by University College London, demonstrated how genetic testing can identify breast cancer patients who may safely avoid chemotherapy. Among 4,000 participants, low-risk individuals were successfully treated with hormone therapy alone. Similarly, new treatment combinations for bladder cancer are helping patients avoid invasive surgery. Despite these encouraging results, experts warn that cancer rates are expected to rise significantly, from 165 cases per 100,000 people in 2025 to 200 by 2050. Annual diagnoses could increase from 20 million to over 35 million globally due to aging populations and demographic changes. Additional studies also highlighted lifestyle factors. Chronic insomnia was linked to a higher risk of several cancers among younger adults, while practices such as yoga were shown to improve mental health and reduce fatigue in patients. Overall, while targeted therapies are advancing rapidly, they are not yet a complete replacement for chemotherapy but represent an important shift toward more personalized cancer care.
Banish CancerValue‑based care replaces volume‑driven treatment with outcome‑driven support.
It prioritizes patient goals, coordinated care, shared decision‑making, and evidence‑based treatment pathways.
Bundled care models reduce financial stress, while multidisciplinary teams improve quality of life and symptom management.
Visit Banish Cancer Blog for more.
#ValueBasedCare #CancerTreatment #HealthEquity #BanishCancer
All Scientifical🎗️ What can chemotherapy affect? #oncology #chemotherapy #cancertreatment #cancerawareness ... Continue to: https://www.youtube.com/watch?v=QJqHfJKEFSc
Which is not a common side effect of chemotherapy?
A. Hair loss
B. Nausea
C. Increased appetite
D. Fatigue
#sideeffects #chemotherapy #oncology #cancertreatment ... Continue to: https://www.facebook.com/1130092409221646/posts/1345202174377334
A. Hair loss
B. Nausea
C. Increased appetite
D. Fatigue
#sideeffects #chemotherapy #oncology #cancertreatment ... Continue to: https://www.facebook.com/1130092409221646/posts/1345202174377334
Which cells are most affected by chemotherapy?
A) Fat cells
B) Rapidly dividing cells
C) Bone cells
D) Nerve cells
#cells #chemotherapy #cancertreatment #oncology ... Continue to: https://www.facebook.com/1130092409221646/posts/1343762221187996
A) Fat cells
B) Rapidly dividing cells
C) Bone cells
D) Nerve cells
#cells #chemotherapy #cancertreatment #oncology ... Continue to: https://www.facebook.com/1130092409221646/posts/1343762221187996
CohninaCancer jab can eradicate entire tumours in patients, trial shows
"The jab, called amivantamab, shrank the tumours of more than a third of patients, with dramatic changes seen within weeks. In 15 of them, doctors found the drug had melted away their tumours altogether."
Path-IHI Project🟢 25-31 May - European Week Against Cancer
🔬 Day 5 - Research
⚕️ Cancer is the leading cause of death for people aged 45-64 in an increasing number of EU countries. EU-funded projects are driving cutting-edge research and innovation.
PATH Project is one of them, aiming to build a powerful AI-driven platform designed to support clinicians in delivering more precise, timely, and effective #CancerTreatment, reflecting a collaborative and multidisciplinary approach to European health innovation.
🔬 Day 5 - Research
⚕️ Cancer is the leading cause of death for people aged 45-64 in an increasing number of EU countries. EU-funded projects are driving cutting-edge research and innovation.
PATH Project is one of them, aiming to build a powerful AI-driven platform designed to support clinicians in delivering more precise, timely, and effective #CancerTreatment, reflecting a collaborative and multidisciplinary approach to European health innovation.
The Hard Times – Punk News Comin’ Your Way! [Unofficial]Hospital Billing Department Determined To Keep Battling Patient Long After Cancer Has Given Up
